Unknown

Dataset Information

0

Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions.


ABSTRACT: Low back pain (LBP) is a major reason for disability, and symptomatic intervertebral disc (IVD) degeneration (IDD) contributes to roughly 40% of all LBP cases. Current treatment modalities for IDD include conservative and surgical strategies. Unfortunately, there is a significant number of patients in which conventional therapies fail with the result that these patients remain suffering from chronic pain and disability. Furthermore, none of the current therapies successfully address the underlying biological problem - the symptomatic degenerated disc. Both spinal fusion as well as total disc replacement devices reduce spinal motion and are associated with adjacent segment disease. Thus, there is an unmet need for novel and stage-adjusted therapies to combat IDD. Several new treatment options aiming to regenerate the IVD are currently under investigation. The most common approaches include tissue engineering, growth factor therapy, gene therapy, and cell-based treatments according to the stage of degeneration. Recently, the regenerative activity of small molecules (low molecular weight organic compounds with less than 900 daltons) on IDD was demonstrated. However, small molecule-based therapy in IDD is still in its infancy due to limited knowledge about the mechanisms that control different cell signaling pathways of IVD homeostasis. Small molecules can act as anti-inflammatory, anti-apoptotic, anti-oxidative, and anabolic agents, which can prevent further degeneration of disc cells and enhance their regeneration. This review pursues to give a comprehensive overview of small molecules, focusing on low molecular weight organic compounds, and their potential utilization in patients with IDD based on recent in vitro, in vivo, and pre-clinical studies.

SUBMITTER: Kamali A 

PROVIDER: S-EPMC7681102 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions.

Kamali Amir A   Ziadlou Reihane R   Lang Gernot G   Pfannkuche Judith J   Cui Shangbin S   Li Zhen Z   Richards R Geoff RG   Alini Mauro M   Grad Sibylle S  

Theranostics 20210101 1


Low back pain (LBP) is a major reason for disability, and symptomatic intervertebral disc (IVD) degeneration (IDD) contributes to roughly 40% of all LBP cases. Current treatment modalities for IDD include conservative and surgical strategies. Unfortunately, there is a significant number of patients in which conventional therapies fail with the result that these patients remain suffering from chronic pain and disability. Furthermore, none of the current therapies successfully address the underlyi  ...[more]

Similar Datasets

| S-EPMC10359191 | biostudies-literature
| S-EPMC7097980 | biostudies-literature
| S-EPMC9679278 | biostudies-literature
| S-EPMC8207249 | biostudies-literature
2024-04-05 | GSE230809 | GEO
| PRJNA962588 | ENA
| S-EPMC7393939 | biostudies-literature
| S-EPMC8306701 | biostudies-literature
| S-EPMC5939980 | biostudies-literature
| S-EPMC3162326 | biostudies-literature